关于非酒精性型肝炎临床试验的最新情况
Rohit R Nathani1, Meena B Bansal2
1Department of Medicine, Mount Sinai West and Morningside Hospital, New York, New York.
尽管进行了数十年的研究,但对于非酒精性脂肪性肝病/非酒精性脂肪性肝炎 (NAFLD/NASH) 尚无批准的治疗方法. 目前正在进行的试验和新兴的候选药物为治疗这种复杂的肝病提供了希望.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 翻译医学是一种翻译医学.
背景情况:
- 非酒精性脂肪肝/非酒精性脂肪肝炎 (NAFLD/NASH) 是一种复杂的肝病,没有经批准的治疗方法.
- 主要的致病驱动因素包括肝脏脂毒性和de novo脂质生成,受遗传学和环境因素的影响.
研究的目的:
- 审查NAFLD/NASH的病理生理学.
- 讨论药物点和从临床试验中吸取的经验教训.
- 概述目前NASH临床试验的情况.
主要方法:
- 对NAFLD/NASH病理生理学现有文献的综述.
- 对NASH疗法的已完成和正在进行的临床试验结果的分析.
- 检查新兴的治疗点和候选药物.
主要成果:
- 已经确定了多个治疗点,但早期试验面临挑战.
- 目前正在进行的第二阶段和第三阶段试验显示出有希望的结果,一些药物接近潜在的批准.
- 了解疾病异质性对于成功的治疗开发至关重要.
结论:
- 尽管过去出现了挫折,但NAFLD/NASH治疗领域正在取得进展.
- 新的候选药物和正在进行的临床试验代表了重大进展.
- 个性化方法可能是必要的,以解决NAFLD/NASH的异质性.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
